Home › Companies › CLOVER HEALTH INVESTMENTS CORP. › 2023-2024

CLOVER HEALTH INVESTMENTS CORP. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and CLOVER HEALTH INVESTMENTS CORP.’s Form 8-K, filed 2024-06-13 (Item 5.07 on EDGAR). Page generated 02 October 2026.

7Reported items
100Asset managers
278Fund votes
2024-06-10Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore CLOVER HEALTH INVESTMENTS CORP. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by CLOVER HEALTH INVESTMENTS CORP.

These tallies are CLOVER HEALTH INVESTMENTS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-13 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

CLOVER HEALTH INVESTMENTS CORP. — official shareholder meeting results, meeting held 2024-06-10
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Chelsea Clinton	937,120,902	--	--	26,227,596	145,211,573	Majority: yes
Elect Director: Carladenise Armbrister Edwards	942,172,343	--	--	21,176,155	145,211,573	Majority: yes
Elect Director: Vivek Garipalli	941,392,586	--	--	21,955,912	145,211,573	Majority: yes
Proposal 2: Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2023	950,591,272	10,963,460	1,793,766	--	145,211,573	Majority: yes
Proposal 3: Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2024	1,100,958,512	5,333,701	2,267,858	--	--	Majority: yes

Source: CLOVER HEALTH INVESTMENTS CORP., Form 8-K, filed with the SEC on 2024-06-13 — read the filing on EDGAR.

How asset managers voted at the CLOVER HEALTH INVESTMENTS CORP. 2023-2024 meeting

Each item below shows how the 100 asset managers that disclosed a CLOVER HEALTH INVESTMENTS CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CLOVER HEALTH INVESTMENTS CORP.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. NON-BINDING ADVISORY PROPOSAL TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS FOR 2023.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-06-10.

Combines 9 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 950,591,272AGAINST: 10,963,460

CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“Proposal 2: Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2023”): 950,591,272 for, 10,963,460 against, per its Form 8-K filed 2024-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 97 asset managers below cast 94% of the shares they voted on this item FOR (34,464,999 for, 2,086,374 against).

FOR 94%

FOR: 34,464,999 (94.3%)AGAINST: 2,086,374 (5.7%)

Largest asset managers voting on “NON-BINDING ADVISORY PROPOSAL TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS FOR 2023.” at CLOVER HEALTH INVESTMENTS CORP., 2023-2024
Asset manager	For	Against	Vote
Charles Schwab	6,200,560	0	For
BlackRock	6,137,478	0	For
Renaissance	5,411,890	0	For
Vanguard	4,635,448	0	For
JUPITER ASSET MANAGEMENT LTD	4,525,079	0	For
DE Shaw	1,838,140	0	For
Two Sigma	1,573,966	0	For
Invesco	817,598	0	For
Allianz	0	786,333	Against
GMT CAPITAL CORP	0	701,600	Against
Connor, Clark & Lunn Investment Management Ltd.	540,663	0	For
State Street	520,250	0	For
Northern Trust	443,118	0	For
Voya	326,248	0	For
UBS	0	274,212	Against
Fidelity	266,870	0	For
Legal & General Investment Management America Inc	165,279	0	For
Legal & General Investment Management Ltd	165,279	0	For
Point72	126,910	0	For
MELLON INVESTMENTS Corp	121,924	0	For
Dimensional	0	94,128	Against
REGIONS FINANCIAL CORP	91,500	0	For
GEODE CAPITAL MANAGEMENT, LLC	89,624	0	For
JACOBS LEVY EQUITY MANAGEMENT, INC	85,061	0	For
Aureus Asset Management, LLC	0	79,000	Against

Showing the 25 largest of 97 asset managers. See all 97 in the interactive database.

2. ELECTION OF DIRECTORS: Carladenise Armbrister Edwards

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-10.

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 942,172,343WITHHELD: 21,176,155

CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“Elect Director: Carladenise Armbrister Edwards”): 942,172,343 for, 21,176,155 withheld, per its Form 8-K filed 2024-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 11 asset managers below cast 100% of the shares they voted on this item FOR (8,172,373 for, 0 against).

FOR 98%

FOR: 8,172,373 (97.7%)ABSTAIN: 188,241 (2.3%)

Largest asset managers voting on “ELECTION OF DIRECTORS: Carladenise Armbrister Edwards” at CLOVER HEALTH INVESTMENTS CORP., 2023-2024
Asset manager	For	Abstain	Vote
Vanguard	4,392,317	0	For
Charles Schwab	3,100,280	0	For
Invesco	403,162	0	For
Fidelity	265,255	0	For
Voya	0	163,124	Abstain
Blackstone Alternative Investment Funds	0	16,600	Abstain
BlackRock	9,673	0	For
John Hancock	0	6,044	Abstain
Nationwide	0	1,916	Abstain
State Street	1,686	0	For
Victory Capital	0	557	Abstain

3. ELECTION OF DIRECTORS: Chelsea Clinton

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-10.

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 937,120,902WITHHELD: 26,227,596

CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“Elect Director: Chelsea Clinton”): 937,120,902 for, 26,227,596 withheld, per its Form 8-K filed 2024-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 11 asset managers below cast 100% of the shares they voted on this item FOR (4,588,936 for, 0 against).

FOR 54.9%ABSTAIN 45.1%

FOR: 4,588,936 (54.9%)ABSTAIN: 3,771,678 (45.1%)

Largest asset managers voting on “ELECTION OF DIRECTORS: Chelsea Clinton” at CLOVER HEALTH INVESTMENTS CORP., 2023-2024
Asset manager	For	Abstain	Vote
Vanguard	4,392,317	0	For
Charles Schwab	0	3,100,280	Abstain
Invesco	0	403,162	Abstain
Fidelity	185,260	79,995	For
Voya	0	163,124	Abstain
Blackstone Alternative Investment Funds	0	16,600	Abstain
BlackRock	9,673	0	For
John Hancock	0	6,044	Abstain
Nationwide	0	1,916	Abstain
State Street	1,686	0	For
Victory Capital	0	557	Abstain

4. ELECTION OF DIRECTORS: Vivek Garipalli

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-10.

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 941,392,586WITHHELD: 21,955,912

CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“Elect Director: Vivek Garipalli”): 941,392,586 for, 21,955,912 withheld, per its Form 8-K filed 2024-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 11 asset managers below cast 100% of the shares they voted on this item FOR (8,170,687 for, 0 against).

FOR 98%

FOR: 8,170,687 (97.7%)ABSTAIN: 189,927 (2.3%)

Largest asset managers voting on “ELECTION OF DIRECTORS: Vivek Garipalli” at CLOVER HEALTH INVESTMENTS CORP., 2023-2024
Asset manager	For	Abstain	Vote
Vanguard	4,392,317	0	For
Charles Schwab	3,100,280	0	For
Invesco	403,162	0	For
Fidelity	265,255	0	For
Voya	0	163,124	Abstain
Blackstone Alternative Investment Funds	0	16,600	Abstain
BlackRock	9,673	0	For
John Hancock	0	6,044	Abstain
Nationwide	0	1,916	Abstain
State Street	0	1,686	Abstain
Victory Capital	0	557	Abstain

5. The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2024-06-10.

Combines 3 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%

FOR: 1,100,958,512AGAINST: 5,333,701

CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“Proposal 3: Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2024”): 1,100,958,512 for, 5,333,701 against, per its Form 8-K filed 2024-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 11 asset managers below cast 100% of the shares they voted on this item FOR (8,360,614 for, 0 against).

FOR 100%

FOR: 8,360,614 (100.0%)

Largest asset managers voting on “The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accoun” at CLOVER HEALTH INVESTMENTS CORP., 2023-2024
Asset manager	For	Vote
Vanguard	4,392,317	For
Charles Schwab	3,100,280	For
Invesco	403,162	For
Fidelity	265,255	For
Voya	163,124	For
Blackstone Alternative Investment Funds	16,600	For
BlackRock	9,673	For
John Hancock	6,044	For
Nationwide	1,916	For
State Street	1,686	For
Victory Capital	557	For

6. To approve, if necessary, the postponement or adjournment of the Special Meeting to permit further solicitation and vote of proxies in favor of the reverse stock split and authorized shares reduction proposal.

CORPORATE GOVERNANCE

Reported under meeting date 2023-08-29; no official results on file for that date.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (1,124,795 for, 0 against).

FOR: 1,124,795 (100.0%)

Largest asset managers voting on “To approve, if necessary, the postponement or adjournment of the Special Meeting to permit further solicitatio” at CLOVER HEALTH INVESTMENTS CORP., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Charles Schwab	1,118,751	0	0	0	For
John Hancock	6,044	0	0	0	For

7. To authorize our Board of Directors to amend the Company s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company s outstanding shares of Class A common stock and Class B common stock, at a reverse stock split ratio range of 1-for-5 through 1-for-20, as determined by the Company s Board of Directors at a later date, and reduce the number of authorized shar

CAPITAL STRUCTURE

Reported under meeting date 2023-08-29; no official results on file for that date.

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (1,124,795 for, 0 against).

FOR: 1,124,795 (100.0%)

Largest asset managers voting on “To authorize our Board of Directors to amend the Company s Amended and Restated Certificate of Incorporation t” at CLOVER HEALTH INVESTMENTS CORP., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Charles Schwab	1,118,751	0	0	0	For
John Hancock	6,044	0	0	0	For

Largest CLOVER HEALTH INVESTMENTS CORP. shareholders voting in 2023-2024

Ranked by the number of CLOVER HEALTH INVESTMENTS CORP. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 486,374,644 shares outstanding at the time of that meeting.

Top CLOVER HEALTH INVESTMENTS CORP. shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	Charles Schwab	1.27%
2	BlackRock	1.26%
3	Renaissance	1.11%
4	Vanguard	0.95%
5	JUPITER ASSET MANAGEMENT LTD	0.93%
6	DE Shaw	0.38%
7	Two Sigma	0.32%
8	Invesco	0.17%
9	Allianz	0.16%
10	GMT CAPITAL CORP	0.14%

Reported CLOVER HEALTH INVESTMENTS CORP. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

CLOVER HEALTH INVESTMENTS CORP. beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
Vivek Garipalli	18.26%	DEF14A
Entities affiliated with Vivek Garipalli	17.19%	DEF14A
BlackRock	6.25%	13F
Vanguard Group	4.74%	13F
Renaissance Technologies	2.34%	13F
Geode Capital	0.88%	13F
D.E. Shaw	0.76%	13F
Charles Schwab	0.64%	13F
Andrew Toy	0.55%	DEF14A
Two Sigma	0.52%	13F

Percentages above are of 486,374,644 shares outstanding, as reported by CLOVER HEALTH INVESTMENTS CORP. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CLOVER HEALTH INVESTMENTS CORP.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At CLOVER HEALTH INVESTMENTS CORP.'s shareholder meeting held 2024-06-10, in the 2023-2024 proxy season, 100 asset managers reported how they voted in their SEC Form N-PX filings, covering 278 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — NON-BINDING ADVISORY PROPOSAL TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS… — FOR was 99% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CLOVER HEALTH INVESTMENTS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-13.

CLOVER HEALTH INVESTMENTS CORP. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.